Special Communication examines sources of high drug prices in the U.S. and possible solutions to reduce unnecessary burdens on patients while maintaining innovation
WHERE
JAMA
WHO
Aaron S. Kesselheim, MD, JD, MPH, corresponding author of the Special Communication, is an internist and director of the Program on Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology & Pharmacoeconomics at Brigham and Women's Hospital.
WHAT: